Huntsman delivered a quarter where the operating line and the bottom line tell different stories. Adjusted earnings of $0.04 per share missed the $0.07 consensus by 42.9%. Revenue of $1.717 billion beat the $1.60 billion estimate by 7.3%. Revenue grew 17.6% year over year, well ahead of the company's 11% nine-month pace, which points to acceleration into the third quarter. Earnings growth of 233.3% reflects a swing from an adjusted loss of $0.03 a year ago to a small profit. On a GAAP basis, Huntsman still lost $0.10 per share, narrower than the $0.14 loss last year. The central tension is straightforward: the business is earning materially more at the operating level, but very little of that improvement reached shareholders.

The quality of the miss deserves scrutiny, because it was not an operating shortfall. Adjusted EBITDA rose to $132 million from $94 million. Adjusted pre-tax income tripled to $45 million from $15 million. The adjusted effective tax rate, however, jumped to 56% from 40%, and the GAAP rate was 108%. That tax bite, plus $13 million attributable to noncontrolling interests, left just $7 million of adjusted net income. Investors focused on EBITDA will see a clean recovery, while those focused on per-share earnings will see a company that still converts poorly.

Beneath the headline, the mix of growth matters.

• **Polyurethanes:** Revenue rose 21%, but 19 points came from price and only 2 from volume. Segment EBITDA climbed to $75 million from $48 million. The release credits better supply-demand dynamics and higher raw-material costs for MDI pricing.
• **Advanced Materials:** This was the higher-quality grower, with 12% volume growth tied to aerospace, automotive and power markets. Segment EBITDA rose 41% to $62 million.
• **Performance Products:** Volume was essentially flat, and growth came from price.

Polyurethanes volume growth has slowed from the 4% cited for the second quarter, so the segment's improvement now rests largely on pricing. Those pricing gains are partly cost pass-through and may be vulnerable as competitor supply returns.

The conference-call evidence requires an important caveat. The transcript labeled as the third-quarter call is essentially a repeat of the July second-quarter call. That means there is no genuine incremental management commentary for this quarter, and the forward-looking signals below are dated. Those signals had already cooled from first-quarter optimism:

• Management described global MDI demand growth as only 0-2%.
• It noted softening North American housing and weak Chinese consumer confidence.
• It framed the third-quarter outlook as merely "stable."
• It flagged European gas prices rising above $20/MMBtu, a threat to Europe's EBITDA-positive status.
• It said one-time benefits such as an aerospace pull-forward and a polyol outage gain would fade.

The actual third-quarter results arguably came in better than that cautious tone implied, particularly in Advanced Materials.

Cash flow and the balance sheet temper the operating improvement. Free cash flow fell to $82 million from $157 million. Nine-month free cash flow is negative $99 million, driven by a $189 million working-capital build that includes a $214 million increase in receivables. Net debt rose to $1.684 billion from $1.582 billion at year-end. Even so, CEO Peter Huntsman expects better results and cash flow to bring net leverage to roughly 4x by year-end, down from 6.1x after the first quarter. That target implies a heavy fourth-quarter cash inflow and is the most testable near-term commitment.

The Olin merger of equals is the dominant catalyst. Shareholders approved the deal on August 25, U.S. regulators cleared it in September, and closing is now expected in the first quarter of 2027.

• Previously outlined synergies total about $300 million, plus more than $100 million from replacing a chlorine/caustic contract after 2030.
• The S-4 projects roughly $500 million of 2027 EBITDA, but that assumes a moderate housing and economic recovery.
• The deal represents execution risk as well as upside, and the market has treated synergy claims skeptically.

Investor sentiment edged up modestly, from 0.11 to 0.13. That is a small improvement that remains only mildly positive. The price action is less forgiving. Shares at $9.95 are down 9.0% since the open after the July report and sit 15% below the $11.70 200-day moving average. The stock has not been rewarded for the EBITDA recovery, which suggests investors are discounting macro softness, leverage and merger uncertainty.

The bottom line is that Huntsman's operating recovery is real: EBITDA up 40%, revenue accelerating and Advanced Materials volumes surging. A punishing tax rate, weaker cash conversion and price-led Polyurethanes growth kept the per-share result short of expectations. With no fresh call commentary and the stock well below its long-term trend, the investment case now hinges on fourth-quarter cash generation, the European energy backdrop and a timely Olin close.